Imprivata Inc (IMPR) is Downgraded by Piper Jaffray to Neutral

Imprivata Inc (IMPR) was Downgraded by Piper Jaffray to ” Neutral”. Earlier the firm had a rating of “Overweight ” on the company shares. Piper Jaffray advised their investors in a research report released on Jul 13, 2016.

On the company’s financial health, Imprivata Inc reported $-0.21 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on May 3, 2016. Analyst had a consensus of $-0.31. The company had revenue of $31.52 million for the quarter, compared to analysts expectations of $29.28 million. The company’s revenue was up 22.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.24 EPS.

Imprivata Inc opened for trading at $14.42 and hit $14.54 on the upside on Monday, eventually ending the session at $14.37, with a gain of 0.21% or 0.03 points. The heightened volatility saw the trading volume jump to 67,468 shares. Company has a market cap of $364 M.

In a different news, on May 6, 2016, Jeffrey Kalowski (Chief Financial Officer) sold 10,000 shares at $12.98 per share price. According to the SEC, on Apr 29, 2016, Omar Hussain (President and CEO) sold 18,936 shares at $12.12 per share price. On Apr 19, 2016, Thomas W. Brigiotta (SVP, WW Sales and Field Ops) sold 10,000 shares at $12.80 per share price, according to the Form-4 filing with the securities and exchange commission.

Imprivata Inc. is a provider of healthcare information technology) IT security solutions. The Company’s solutions provide authentication management access to patient information and communications technologies to the healthcare industry. Its solutions include Imprivata OneSign Imprivata Cortext and Imprivata Confirm ID. Imprivata OneSign is a suite of authentication and access management products which consists of three offerings: authentication management enterprise single sign-on and workflow automation. Imprivata Cortext is a cloud-supported communications platform that provides healthcare organizations with texting and messaging services. Imprivata Confirm ID is a software product for electronic prescribing of controlled substances (EPCS).

Imprivata Inc

Leave a Reply

Imprivata Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Imprivata Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.